1
2
May 20, 2021 Antiretroviral therapy, the common approach in the treatment of HIV, halts replication of the virus and has saved the lives of millions of people. However, for patients the drug cocktail becomes a ...
Feb. 3, 2022 New research sheds light on the lifespans and location of the cells that are responsible for producing HIV, preventing its eradication. Understanding the cells' dynamics may help scientists ...
May 3, 2022 Researchers contribute to a better understanding of HIV-1 latency: implications for the development of new therapeutic ...
Sep. 29, 2022 Is it ethical to test possible HIV cures by having subjects stop taking antiretroviral therapy and then giving them placebos rather than the experimental treatment? The answer is often yes, according ...
Jan. 13, 2024 In women living with HIV, preventive treatment with DHA-PPQ is a safe and effective strategy to prevent malaria during pregnancy, according to the final results of the MAMAH clinical ...
Jan. 31, 2022 A Phase 1 clinical trial has demonstrated the safety and efficacy of a novel immunotherapy drug in the treatment of ...
Apr. 14, 2022 A very small percentage of people with HIV-1, known as 'post-treatment controllers' (PTCs), are able to control their infection after interrupting all antiretroviral therapy. Understanding ...
Aug. 8, 2023 Some HIV-1 carriers who have received an early antiretroviral treatment during several years are able to control the virus for a long term after treatment interruption. However, the mechanisms ...
Feb. 28, 2023 A research team has shown that, as early as the first days of infection, HIV is able to create reservoirs where it will hide and persist during antiretroviral ...
Oct. 21, 2022 A three-dose course of the hepatitis B vaccine HEPLISAV-B fully protected adults living with HIV who had never been vaccinated against or infected with the hepatitis B virus (HBV), according to new ...